Interactive Brokers Group heads into the post-earnings week with analysts still lifting targets and the stock digesting a strong Q2 beat — the question now is whether the Street's revised numbers have finally caught up with the price.
The analyst revision wave accelerated further on Tuesday. BMO Capital raised its target to $110 from $105, maintaining Outperform. Barclays moved to $114 from $108, also keeping Overweight — the firm's second raise in two weeks. Both actions came on July 22, the day after the Q3 reporting date embedded in the data, and push the consensus mean to $105.41. Against a close of $94.42, that implies roughly 12% upside to the average target. The direction remains unambiguous: every firm in the recent change log has raised, none have cut, and the bullish trajectory traces back through Piper Sandler's $105 raise on July 15 and BofA's $106 lift on July 14. EPS momentum underpins the conviction — the 30-day rank is in the 87th percentile and the 90-day in the 77th. The one persistent bear argument is forward earnings growth, where the 12-month forward EPS growth rank sits in the 36th percentile, suggesting the market is pricing in a pace of expansion that estimates don't fully support.
Positioning is loose by almost every measure — this is not a stock with meaningful short-side tension. Short interest is 2.5% of the free float, down 13% over the past month and continuing a steady retreat that began in early July. The lending market confirms the lack of conviction among bears: borrow costs have fallen sharply, running at just 0.27% — down roughly 26% on the week and 28% over the past month. Availability is effectively uncapped, with more than 400 million shares available to borrow relative to the roughly 11 million currently shorted. That ratio is not a typo; it reflects how thin the short base is against the overall float. Options lean the same way. The put/call ratio is 0.55, marginally below its 20-day average of 0.56, with the z-score at negative 1.1. Call buyers remain in modest control — not an extreme reading, but consistent with a market that sees limited reason to hedge.
What changed last week deserves naming explicitly, since it contradicts some of the pre-earnings setup described in earlier coverage. The July 21 print marked a second quarterly reporting event — data shows an earnings entry on that date — and the post-earnings price action has shifted the stock to $94.42, up 3% on the day, though still down about 1.2% on the week. Short interest, which was holding near 14 million shares through early July, dropped sharply around July 10 to roughly 11.3 million — a ~22% decline in a matter of days. That move almost certainly reflects shorts covering into and after the results, rather than any change in the fundamental bear case. The short score has eased accordingly, sitting at 32.3 and barely moving over the past week.
The peer context adds a wrinkle. Morgan Stanley and Goldman Sachs each rose about 2.9% on Tuesday but are down roughly 5% and 4.8% on the week respectively, underperforming IBKR's weekly performance on a relative basis. Robinhood surged 7.1% on Tuesday — the biggest single-day gain in the peer group — though it too has slid 6.2% on the week. The divergence suggests IBKR's post-earnings resilience is stock-specific rather than a sector-wide bid.
The next scheduled earnings date is October 13. Between now and then, the central tension worth tracking is whether the stock can close the remaining gap to the freshly lifted analyst targets — and whether the forward EPS growth picture improves enough to give those targets a firmer fundamental foundation.
See the live data behind this article on ORTEX.
Open IBKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
